Background: Positive transcription elongation factor b (P-TEFb) complexes are crucial for allowing the elongation of RNA by RNA polymerase II (RNAPII). These complexes are able to phosphorylate the carboxyl-terminal domain of the largest RNAPII subunit. P-TEFb complexes are made up of a catalytic subunit, cyclin dependent kinase 9 (Cdk9), and one of the regulatory cyclins, CycT1, CycT2a, CycT2b or cyclin K. Specifically, cyclin K forms an active P-TEFb complex with Cdk9. This complex promotes transcription by phosphorylating the carboxyl-terminal domain of RNAPII which allows the elongation of transcription to proceed. Cyclin K is ubiquitously expressed in adult mouse and human tissues, with highest levels expressed in the developing germ cells of adult testis and ovaries. Cyclin K is also present in HepG2 cells. The cyclin K gene encodes a 357 amino acid protein and maps to human chromosome 14q32.
Description: Rabbit polyclonal to Cyclin Y
Immunogen: KLH conjugated synthetic peptide derived Cyclin Y
Specificity: ·Reacts with Human, Mouse and Rat.
·Isotype: IgG
Application: ·Western blotting: 1/100-500. Predicted Mol wt: 66 kDa;
·Immunohistochemistry (Paraffin/frozen tissue section): 1/50-200;
·Immunocytochemistry/Immunofluorescence: 1/100;
·Immunoprecipitation: 1/50;
·ELISA: 1/500;
·Optimal working dilutions must be determined by the end user.
